Correction to: Restoration of antioxidant enzymes in the therapeutic use of selenium in septic patients (Wiener klinische Wochenschrift, (2013), 125, 11-12, (316-325), 10.1007/s00508-013-0371-x);Restoration of antioxidant enzymes in the therapeutic use of selenium in septic patients

Wiener Klinische Wochenschrift

Volumn 125, Issue 11-12, 2013, Pages 316-325

  Janka, Vašková ^a   Ladislav, Kočan ^b   Jozef, Firment ^b   Ladislav, Vaško ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

Author keywords

Artificial nutrition; Oxidative stress; Selenium; Sepsis

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; PLACEBO; SERUM ALBUMIN; SODIUM SELENITE; SUPEROXIDE;

ADULT; AGED; APACHE; ARTICLE; CONTINUOUS INFUSION; ENZYME ACTIVITY; FEMALE; HUMAN; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SUPPLEMENTATION; TREATMENT DURATION;

EID: 84879620664     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-023-02191-7     Document Type: Erratum

References (32)

1. Andrews PJ, Avenell A, Noble DW, Campbell MK, Croal BL, Simpson WG, Vale LD, Battison CG, Jenkinson DJ, Cook JA, Scottish Intensive care Glutamine or seleNium Evaluative Trial Trials Group. Randomized trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ. 2011; 342:d1542, doi:10.1136/bmj.d1542.
2. Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, Strauss R, meier-Hellmann A, Insel R, Radke J, Schüttler J, Gärtner R. Selenium in Intensive Care (SIC): results of a prospective, randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med. 2007;35(1):118-26.
3. Bela P, Bahl R, Sane AS, Sawant PH, Shah VR, Mishra VV, Trivedi HL. Oxidative stress status: possible guideline for clinical management of critically ill patients. Panminerva Med. 2001;43(1):27-31.
4. Bhat MA, Bhat JI, Kawoosa MS, Ahmad SM, Ali SW. Organism-specific platelet response and factors affecting survival in thrombocytopenic very low birth weight babies with sepsis. J Perinatol. 2009;29(10):702-8.
5. Blakytny R, Harding JJ. Glycation (non-enzymic glycosylation) inactivates glutathione reductase. Biochem J. 1992;288(Pt 1):303-7.
6. Briz O, Romero MR, Martinez-Becerra P, Macias RI, Perez MJ, Jimenez F, San Martin FG, Marin JJ. OATP8/1B3-mediated cotransport of bile acids and glutathione: an export pathway for organic anions from hepatocytes? J Biol Chem. 2006;281(41):30326-35.
7. Chan WS, Dedon CP. The biological and metabolic fates of endogenous DNA damage products. J Nucleic Acids. 2010;13, Article ID 929047, doi:10.4061/2010/929047.
8. de Menezes CC, Dorneles AG, Sperotto RL, Duarte MM, Schetinger MR, Loro VL. Oxidative stress in cerebrospinal fluid of patients with aseptic and bacterial meningitis. Neurochem Res. 2009;34(7):1255-60.
9. Faviere W, Boechat T. Sepsis: thrombocytopenia is bad, not recovering thrombocytopenia is too bad. Crit Care. 2011;15(Supp 1):P440.
10. Finley JW, Duffield A, Ha P, Vanderpool RA, Thomson CD. Selenium supplementation affects the retention of stable isotopes of selenium in human subjects consuming diets low in selenium. Br J Nutr. 1999;82(5):357-60.
11. Firment J, Hudak V, Grendel T. Difficulties in implementation of the recommendations for the diagnosis and treatment of severe sepsis and sepsis shock. Anesteziologie a Intenzivní Medicína 2008;19(5):252-9.
12. Forceville X, Laviolle B, Annane D, Vitoux D, Bleichner G, Korach JM, Cantais E, Georges H, Soubirou JL, Combes A, Bellissant E. Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Crit Care. 2007;11(4):R73.
13. Geoghegan M, McAuley D, Eaton S, Powell-Tuck J. Selenium in critical illness. Curr Opin Crit Care. 2006;12(2):136-41.
14. Hardy G, Hardy I. Selenium: the Se-XY nutraceutical. Nutrition. 2004;20(6):590-3.
15. Heyland D. Selenium supplementation in critically ill patients: can too much of a good thing be a bad thing? Crit Care. 2007;11(4):153.
16. Ince C. The microcirculation is the motor of sepsis. Crit Care. 2005;9(Supp 4):13-9.
17. Kharb S, Singh V, Ghalaut PS, Sharma A, Singh GP. Role of oxygen free radicals in shock. J Assoc Physicians India. 2000;48(10):956-7.
18. Kuklinski B, Zimmermann T, Schweder R. Decreasing mortality in acute pancreatitis with sodium selenite. Clinical results of 4 years antioxidant therapy. Med Klin (Munich). 1995;90 (Supp 1):36-41.
19. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003;29:530-8.
20. Mahagita C, Grassl SM, Piyachaturawat P, and Ballatori N. Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport. Am J Physiol Gastrointest Liver Physiol 2007;293(1):G271-8.
21. Manzanares W, Biestro A, Torre MH, Galusso F, Facchin G, Hardy G. High-dose selenium reduces ventilator-associated pneumonia and illness severity in critically ill patients with systemic inflammation. Intensive Care Med. 2011;37(7):1120-7.
22. Manzanares W, Hardy G. The role of prebiotics and synbiotics in critically ill patients. Curr Opin Clin Nutr Metab Care. 2008;11(6):782-9.
23. Meisner M. Biomarkers of sepsis: clinically useful? Curr Opin Crit Care. 2005;11(5):473-80.
24. Menges T, Engel J, Weters I, Wagner RM, Little S, Ruwoldt R, Wollbrueck M, Hempelmann G. Changes in blood lymphocyte populations after multiple trauma: association with posttraumatic complications. Crit Care Med. 1999;27(4):733-40.
25. Mishra V, Baines M, Perry SE, McLaughlin PJ, Carson J, Wenstone R, Shenkin A. Effect of selenium supplementation on biochemical markers and outcome in critically ill patients. Clin Nutr. 2007;26(1):41-50.
26. Rayman MP. The importance of selenium to human health. Lancet, 2000;356(9225):233-41.
27. Ritter C, Andrades M, Frota Júnior ML, Bonatto F, Pinho RA, Polydoro M, Klamt F, Pinheiro CT, Menna-Barreto SS, Moreira JC, Dal-Pizzol F. Oxidative parameters and mortality in sepsis induced by cecal ligation and perforation. Intensive Care Med. 2003;29(10):1782-9
28. Salama A, Sakr Y, Reinhart K. The role of selenium in critical illness: Basic science and clinical implications. Indian J Crit Care Med. 2007;11(3):127-38.
29. Valenta J, Brodska H, Drabek T, Hendl J, Kazda A. High-dose selenium substitution in sepsis: a prospective randomized clinical trial. Intensive Care Med. 2011;37(5):808-15.
30. Wollin MS, Ahmad M, Gao Q, Gupte SA. Cytosolic NAD(P)H regulation of redox signaling and vascular oxygen sensing. Antioxid Redox Signal. 2007;9(6):671-8.
31. Záhorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102(1):5-14.
32. Zuurbier CJ, Eerbeek O, Goedhart PT, Struys EA, Verhoeven NM, Jakobs C, Ince C. Inhibition of the pentose phosphate pathway decreases ischemia-reperfusion-induced creatine kinase release in the heart. Cardiovascular Res. 2004;62:145-53.